PMC:7094172 / 26437-26594 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T404","span":{"begin":65,"end":74},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T403","span":{"begin":148,"end":156},"obj":"SP_7"}],"text":"This conservation may provide certain advantages when developing compounds with broad-spectrum activity against a target pathogen family, including COVID-19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T97","span":{"begin":148,"end":156},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"This conservation may provide certain advantages when developing compounds with broad-spectrum activity against a target pathogen family, including COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T197","span":{"begin":95,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T198","span":{"begin":112,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"This conservation may provide certain advantages when developing compounds with broad-spectrum activity against a target pathogen family, including COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T203","span":{"begin":0,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This conservation may provide certain advantages when developing compounds with broad-spectrum activity against a target pathogen family, including COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"435","span":{"begin":148,"end":156},"obj":"Disease"}],"attributes":[{"id":"A435","pred":"tao:has_database_id","subj":"435","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This conservation may provide certain advantages when developing compounds with broad-spectrum activity against a target pathogen family, including COVID-19."}